Remepy
Founded 2022 · 86 employees on LinkedIn · 9 known investors
Remepy develops "Hybrid Drugs" that combine pharmaceuticals with targeted digital interventions to deliver personalized and adaptive therapies for patients. It operates in the digital health and biotech space, aiming to treat conditions through a combination of biology, behavior, and technology.
Founders & leadership
Remepy was founded in 2022 by Or Shoval.
OS
Or ShovalinCo-Founder & Co-CEO
Investors · 9
97212 VenturesNew York · $150K – $500K
fresh.fund
IT-Farm CorporationTokyovia Julien Nguyen · inferred
NFXSan Francisco · $250K – $5M
O.G. Venture PartnersTel Aviv-Yafo · $5M – $15M
PsyMed VenturesBerkeley
Samsung NextSan Jose · $100K – $5M
Vine VenturesNew York · $1M – $10M
Supernode VenturesreportedNew York · $500K – $1.3M
Competitors · 3
by search overlapBioworld3 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Biosapien3 shared keywordsBiosapien develops treatments for cancer that are delivered locally to shrink tumors, relieve symptoms, and reduce the need for surgeries.
Remedy Plan3 shared keywordsRemedy Plan is a biopharmaceutical company developing drugs that target NAMPT, an essential enzyme dysregulated in more than 20 diseases including cancer. Its lead clinical candidate, RPT1G, is a hyperbolic inhibitor designed to reduce NAMPT activity while avoiding the toxicity that has limited earlier attempts.
Companies competing with Remepy for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Remepy do?
- Remepy develops "Hybrid Drugs" that combine pharmaceuticals with targeted digital interventions to deliver personalized and adaptive therapies for patients. It operates in the digital health and biotech space, aiming to treat conditions through a combination of biology, behavior, and technology.
- Who founded Remepy?
- Remepy was founded by Or Shoval in 2022.
- Who are Remepy's investors?
- Remepy's investors include 97212 Ventures, fresh.fund, IT-Farm Corporation, NFX, O.G. Venture Partners, PsyMed Ventures, Samsung Next, Vine Ventures and 1 more.